Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Addus HomeCare
(NASDAQ:ADUS)
Intraday
$94.54
2.84
[3.10%]
After-Hours
$94.54
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$94.54
2.84
[3.10%]
At close: Apr 26
$94.54
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Q1 2024 Earnings in 8 days from now on Mon May 6th, after the market close
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Addus HomeCare Stock (NASDAQ:ADUS)
Addus HomeCare Stock (NASDAQ: ADUS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 23, 2024
Cracking The Code: Understanding Analyst Reviews For Addus HomeCare
Benzinga Insights
-
5 days ago
Barclays Downgrades Addus HomeCare to Underweight, Announces $83 Price Target
Benzinga Newsdesk
-
5 days ago
Tuesday, March 26, 2024
4 Analysts Assess Addus HomeCare: What You Need To Know
Benzinga Insights
-
Mar 26, 2024, 2:01PM
Oppenheimer Maintains Outperform on Addus HomeCare, Maintains $118 Price Target
Benzinga Newsdesk
-
Mar 26, 2024, 10:05AM
Wednesday, March 06, 2024
Barclays Initiates Coverage On Addus HomeCare with Equal-Weight Rating, Announces Price Target of $88
Benzinga Newsdesk
-
Mar 6, 2024, 6:14AM
Thursday, February 29, 2024
RBC Capital Reiterates Outperform on Addus HomeCare, Maintains $102 Price Target
Benzinga Newsdesk
-
Feb 29, 2024, 11:49AM
Monday, February 26, 2024
Addus HomeCare Q4 EPS $1.32 Beats $1.17 Estimate, Sales $276.35M Beat $274.44M Estimate
Happy Mohamed
-
Feb 26, 2024, 4:05PM
Earnings Scheduled For February 26, 2024
Benzinga Insights
-
Feb 26, 2024, 4:47AM
Friday, February 23, 2024
A Preview Of Addus HomeCare's Earnings
Benzinga Insights
-
Feb 23, 2024, 10:00AM
Monday, February 05, 2024
William Blair Assumes Addus HomeCare at Outperform
Benzinga Newsdesk
-
Feb 5, 2024, 8:22AM
Wednesday, January 17, 2024
Peeling Back The Layers: Exploring Addus HomeCare Through Analyst Insights
Benzinga Insights
-
Jan 17, 2024, 11:00AM
Oppenheimer Reiterates Outperform on Addus HomeCare, Maintains $118 Price Target
Benzinga Newsdesk
-
Jan 17, 2024, 10:42AM
Tuesday, December 12, 2023
TD Cowen Initiates Coverage On Addus HomeCare with Outperform Rating, Announces Price Target of $105
Benzinga Newsdesk
-
Dec 12, 2023, 8:34AM
Wednesday, November 01, 2023
RBC Capital Maintains Outperform on Addus HomeCare, Lowers Price Target to $102
Benzinga Newsdesk
-
Nov 1, 2023, 12:01PM
Stephens & Co. Maintains Overweight on Addus HomeCare, Lowers Price Target to $105
Benzinga Newsdesk
-
Nov 1, 2023, 10:05AM
Monday, October 30, 2023
Addus HomeCare Q3 Adj $1.15 Beats $1.08 Estimate, Sales $270.70M Beat $267.18M Estimate
Benzinga Newsdesk
-
Oct 30, 2023, 4:30PM
Earnings Scheduled For October 30, 2023
Benzinga Insights
-
Oct 30, 2023, 6:11AM
Friday, October 27, 2023
Earnings Outlook For Addus HomeCare
Benzinga Insights
-
Oct 27, 2023, 11:01AM
Wednesday, August 09, 2023
Massive Insider Trade At Addus HomeCare
Benzinga Insights
-
Aug 9, 2023, 11:03AM
Wednesday, August 02, 2023
Oppenheimer Reiterates Outperform on Addus HomeCare, Maintains $118 Price Target
Benzinga Newsdesk
-
Aug 2, 2023, 7:51AM
Raymond James Maintains Outperform on Addus HomeCare, Raises Price Target to $105
Benzinga Newsdesk
-
Aug 2, 2023, 7:39AM
Stephens & Co. Maintains Overweight on Addus HomeCare, Raises Price Target to $110
Benzinga Newsdesk
-
Aug 2, 2023, 7:12AM
Tuesday, August 01, 2023
The Latest Analyst Ratings for Addus HomeCare
Benzinga Insights
-
Aug 1, 2023, 12:00PM
Stephens & Co. Reiterates Overweight on Addus HomeCare, Maintains $100 Price Target
Benzinga Newsdesk
-
Aug 1, 2023, 10:40AM
Monday, July 31, 2023
Addus HomeCare Q2 Adj EPS $1.07 Beats $1.00 Estimate, Sales $259.98M Beat $255.56M Estimate
Benzinga Newsdesk
-
Jul 31, 2023, 4:07PM
Earnings Scheduled For July 31, 2023
Benzinga Insights
-
Jul 31, 2023, 6:31AM
Friday, July 28, 2023
Addus HomeCare's Earnings: A Preview
Benzinga Insights
-
Jul 28, 2023, 10:01AM
Thursday, June 29, 2023
Analyst Expectations for Addus HomeCare's Future
Benzinga Insights
-
Jun 29, 2023, 1:00PM
Oppenheimer Reiterates Outperform on Addus HomeCare, Maintains $118 Price Target
Benzinga Newsdesk
-
Jun 29, 2023, 12:32PM
Addus HomeCare Corporation To Acquire Tennessee Quality Care Operations, Terms Not Disclosed
Benzinga Newsdesk
-
Jun 29, 2023, 8:02AM
Friday, May 26, 2023
Here's Why You Should Retain CVS Health Stock for Now
Zacks
-
May 26, 2023, 1:30PM
Oppenheimer Reiterates Outperform on Addus HomeCare, Maintains $118 Price Target
Benzinga Newsdesk
-
May 26, 2023, 11:18AM
Friday, May 05, 2023
Raymond James Maintains Outperform on Addus HomeCare, Lowers Price Target to $100
Benzinga Newsdesk
-
May 5, 2023, 5:07AM
Wednesday, May 03, 2023
RBC Capital Maintains Outperform on Addus HomeCare, Lowers Price Target to $109
Benzinga Newsdesk
-
May 3, 2023, 9:59AM
4 Analysts Have This to Say About Addus HomeCare
Benzinga Insights
-
May 3, 2023, 9:01AM
Oppenheimer Maintains Outperform on Addus HomeCare, Lowers Price Target to $118
Benzinga Newsdesk
-
May 3, 2023, 6:36AM
Tuesday, May 02, 2023
Stephens & Co. Reiterates Overweight on Addus HomeCare, Maintains $123 Price Target
Benzinga Newsdesk
-
May 2, 2023, 7:56AM
Monday, May 01, 2023
Addus HomeCare Q1 EPS $0.97 Beats $0.87 Estimate, Sales $251.60M Beat $250.06M Estimate
Happy Mohamed
-
May 1, 2023, 4:22PM
What Is Going On With Addus HomeCare Stock Today
Anusuya Lahiri
-
May 1, 2023, 12:37PM
Earnings Scheduled For May 1, 2023
Benzinga Insights
-
May 1, 2023, 7:19AM
Friday, April 28, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Apr 28, 2023, 1:31PM
Why First Republic Bank Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Apr 28, 2023, 1:11PM
A Preview Of Addus HomeCare's Earnings
Benzinga Insights
-
Apr 28, 2023, 11:01AM
US Stocks Mixed; Amazon Posts Upbeat Results
Lisa Levin
-
Apr 28, 2023, 10:07AM
Wednesday, April 05, 2023
Stephens & Co. Reiterates Overweight on Addus HomeCare, Maintains $123 Price Target
Benzinga Newsdesk
-
Apr 5, 2023, 7:46AM
Monday, March 06, 2023
RBC Capital Maintains Outperform on Addus HomeCare, Raises Price Target to $123
Benzinga Newsdesk
-
Mar 6, 2023, 8:03AM
Monday, February 27, 2023
Addus HomeCare Q4 Adj. EPS $1.11 Beats $0.95 Estimate, Sales $247.05M Beat $246.15M Estimate
Michael Horton
-
Feb 27, 2023, 4:09PM
Earnings Scheduled For February 27, 2023
Benzinga Insights
-
Feb 27, 2023, 4:46AM
Friday, February 24, 2023
Addus HomeCare's Earnings: A Preview
Benzinga Insights
-
Feb 24, 2023, 9:01AM
Thursday, November 24, 2022
Massive Insider Trade At Addus HomeCare
Benzinga Insights
-
Nov 24, 2022, 10:05AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch